Drug intelligence / Profile preview

gandouling

Development stage
Phase 4
Lead developer
First Affiliated Hospital of Anhui University of Chinese Medicine
Administration
Oral
01

Overview

Gandouling is a Traditional Chinese Medicine (TCM) formula developed for the treatment of Wilson's disease, also known as hepatolenticular degeneration. It was created by researchers at the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, notably Jun Li. The formula is designed to facilitate the clearance of excess copper from the body, addressing the underlying pathology of Wilson's disease. Clinical studies, including Phase 4 trials, have evaluated its efficacy and safety both as a monotherapy and in combination with standard treatments like zinc gluconate. It is available in tablet and capsule forms and is recognized for its role in improving clinical symptoms and liver function in affected patients.

Brand names
Gandouling
Other names
GandulingGandouling tabletGandouling capsule
02

Targets

Heat shock factor 1 (HSF1) / Heat shock protein beta-1 (HSPB1) pathwayDRD2 (Dopamine D2 Receptor)ORAI2 (Orai calcium release-activated calcium modulator 2)

Beyond the preview

Go deeper on gandouling.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gandouling.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call